What are the appropriate dosages of ofloxacin and Augmentin (amoxicillin/clavulanate) for treating an ear infection with a perforated tympanic membrane?

Ofloxacin and Augmentin Dosing for Ear Infections with Tympanic Membrane Rupture

For ear infections with tympanic membrane perforation, use topical ofloxacin otic solution 0.3% as first-line therapy rather than oral Augmentin, as topical antibiotics achieve superior clinical outcomes with fewer adverse effects.

Ofloxacin Otic Dosing (FDA-Approved)

For Chronic Suppurative Otitis Media with Perforated TM (≥12 years)

• Dose: 10 drops (0.5 mL = 1.5 mg ofloxacin) into affected ear twice daily for 14 days 1
• Warm bottle in hand 1-2 minutes before instillation
• Patient lies with affected ear upward
• Pump tragus 4 times after instillation to facilitate middle ear penetration
• Maintain position for 5 minutes

For Acute Otitis Media with Tympanostomy Tubes (1-12 years)

• Dose: 5 drops (0.25 mL = 0.75 mg ofloxacin) into affected ear twice daily for 10 days 1
• Same administration technique as above

For Otitis Externa (6 months-13 years)

• Dose: 5 drops once daily for 7 days 1

For Otitis Externa (≥13 years)

• Dose: 10 drops once daily for 7 days 1

Augmentin (Amoxicillin-Clavulanate) Dosing

When Oral Antibiotics Are Indicated

High-dose formulation for resistant pathogens:

• 90 mg/kg/day of amoxicillin component divided twice daily (maximum 4000 mg/day) 2, 3
• This provides 90 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate
• Duration: 8-10 days for children <2 years; 5 days for older children 2

Standard-dose formulation:

• 40-45 mg/kg/day of amoxicillin component divided twice or three times daily 2, 4

Clinical Decision Algorithm

Step 1: Assess Tympanic Membrane Status

If TM perforation or tympanostomy tubes present with drainage:

• Use topical ofloxacin otic solution as monotherapy 5
• Oral antibiotics are unnecessary unless child is systemically ill 5
• Topical therapy achieves 77-96% clinical cure vs. 30-67% with oral antibiotics 5

Rationale: Topical antibiotics deliver drug concentrations of 389-2850 mcg/g in otorrhea—far exceeding systemic levels—and provide superior bacterial eradication (96% vs. 67%) with significantly fewer adverse events (6% vs. 31%) 6, 7

Step 2: Consider Pathogen Coverage

Ofloxacin covers:

• Pseudomonas aeruginosa (critical for perforated TM/tubes)
• Staphylococcus aureus
• Streptococcus pneumoniae
• Haemophilus influenzae
• Moraxella catarrhalis 1, 7

Augmentin covers:

• S. pneumoniae (including penicillin-intermediate strains with high-dose)
• H. influenzae (β-lactamase producing)
• M. catarrhalis (β-lactamase producing)
• Does NOT reliably cover Pseudomonas 4

Step 3: When to Use Oral Augmentin

Reserve oral Augmentin for:

1. Intact tympanic membrane with acute otitis media requiring antibiotics 2
2. Systemic illness (high fever, severe pain, toxic appearance) despite topical therapy 5
3. Treatment failure after 48-72 hours of topical therapy 3
4. Recurrent AOM (≥3 episodes in 6 months or ≥4 in 12 months) 2

Do NOT use oral antibiotics as first-line for:

• Otorrhea through tympanostomy tubes 5
• Chronic suppurative otitis media with perforation 1

Critical Safety Considerations

Ototoxicity Prevention

• Only use ototopically-safe antibiotics (ofloxacin, ciprofloxacin-dexamethasone) for perforated TM 5
• Avoid aminoglycoside ear drops (neomycin, gentamicin) with non-intact TM—these are ototoxic 5
• Ofloxacin shows no ototoxicity in animal or human studies 7

Common Pitfalls

1. Prescribing oral antibiotics for tube otorrhea: This increases adverse events without improving outcomes 5, 6
2. Using aminoglycoside drops with perforation: Risk of permanent hearing loss 5
3. Inadequate dosing of Augmentin: Use 90 mg/kg/day for resistant S. pneumoniae, not standard 40 mg/kg/day 3, 4
4. Prolonged topical antibiotic use: Limit to 10 days to prevent fungal superinfection 5

Treatment Failure Management

If no improvement after 48-72 hours:

• With topical ofloxacin: Consider adding oral antibiotics only if systemically ill 5
• With oral Augmentin: Switch to high-dose formulation or consider intramuscular ceftriaxone (50 mg/kg) 3
• Persistent drainage >7 days: Refer to otolaryngology 5

Evidence Strength

The 2013 AAO-HNS tympanostomy tube guideline 5 provides the strongest evidence, demonstrating topical antibiotics achieve clinical cure rates of 77-96% versus 30-67% with oral antibiotics, with significantly better bacterial eradication (96% vs. 67%, P<0.001) and fewer adverse events (6% vs. 31%, P<0.001). This represents Grade A evidence from multiple RCTs 6, 7.